Companies: 10,795·Total market cap: $144.5T
Heyu Biological Technology Corporation

Heyu Biological Technology Corporation

HYBTOTCHealthcare
$0.35
$-0.25(-41.67%)
Market Cap$361364506
P/E Ratio—
52W High$3.4
52W Low$0.002
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Heyu Biological Technology Corporation (HYBT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001086303 · HYBT · OTC · as of Jun 10, 2026

Filing snapshot

349
Total Filings
10-Q
Latest Form
2026-02-13
Most Recent
1999
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001086303 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-08-11
Fiscal Year End
Aug 11, 2025
Accession No.
0001213900-25-074005
Primary Document
ea0251988-10kt_hong.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001086303 · Accession 0001213900-25-074005

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
CURRENT REPORT
2025-05-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
QUARTERLY REPORT
2026-02-13
View
10-QQuarterly Report
QUARTERLY REPORT
2025-11-13
View
10-QQuarterly Report
QUARTERLY REPORT
2025-08-14
View
10-KT10-KT
TRANSITION REPORT
2025-08-11
View
8-KCurrent Report
CURRENT REPORT
2025-05-13
View
8-KCurrent Report
CURRENT REPORT
2025-04-30
View
10-KAnnual Report
ANNUAL REPORT
2025-03-28
View
10-QQuarterly Report
QUARTERLY REPORT
2024-11-13
View
8-K/ACurrent Report (Amended)
AMENDMENT NO. 1 TO FORM 8-K
2024-08-28
View
10-QQuarterly Report
QUARTERLY REPORT
2024-08-13
View
10-QQuarterly Report
QUARTERLY REPORT
2024-05-15
View
8-KCurrent Report
CURRENT REPORT
2024-05-08
View
10-KAnnual Report
ANNUAL REPORT
2024-04-01
View
8-KCurrent Report
CURRENT REPORT
2024-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2024-04-01
View
Showing 1–15 of 320 filingsForm 4 / 144 hidden· 349 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001086303  |  Exchange: OTC · Healthcare

Heyu Biological Technology Corporation (OTC: HYBT) has submitted 349 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1999. As a Healthcare sector company with CIK 0001086303, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Heyu Biological Technology Corporation's most comprehensive regulatory disclosure. The most recent Heyu Biological Technology Corporation 10-K was filed on 2025-08-11 for fiscal year ending 2025. Historical HYBT 10-K annual reports are available from 1999 through 2025.

Investors researching Heyu Biological Technology Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
SSII SEC Filings →PKBFF SEC Filings →TBGNF SEC Filings →DFHL SEC Filings →ORRRY SEC Filings →GUERF SEC Filings →SMDCF SEC Filings →CSSPF SEC Filings →
→ HYBT Financials→ HYBT Earnings→ HYBT Insider Trades

Frequently Asked Questions

HYBT SEC Filings · 8 questions

Heyu Biological Technology Corporation (HYBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 349 filings and access original documents at no cost. Heyu Biological Technology Corporation's CIK is 0001086303.

HYBT SEC filingsHeyu Biological Technology Corporation SEC documentsfind HYBT 10-K